PCDH19 (protocadherin 19) activators influence cellular communication and adhesion processes by modulating various signaling pathways. Compounds that stimulate adenylyl cyclase catalyze the conversion of ATP to cAMP, a second messenger with widespread roles, including the modulation of cell adhesion and cellular dynamics. This surge in cAMP levels could enhance PCDH19's ability to mediate cell-cell communication by influencing the organization of the cytoskeleton and the formation of adherens junctions. Additionally, activation of beta-adrenergic receptors resulting in elevated cAMP can potentiate PCDH19's involvement in calcium-dependent processes critical for adhesion between cells. Further, agents that activate protein kinase C could phosphorylate substrates that affect the stability and interaction of PCDH19 with the cytoskeleton, thereby bolstering its cell adhesion function.
Other activators that influence PCDH19 function include those that modulate gene expression by activating nuclear receptors, thereby affecting cell differentiation and potentially increasing the expression of PCDH19 in specific tissues. Inhibition of enzymes that alter the stability of the cytoskeleton can also enhance PCDH19-mediated cell adhesion. Compounds that inhibit phosphodiesterases lead to sustained cAMP levels, potentially facilitating PCDH19's role in the formation and maintenance of cell-cell junctions. Additionally, the modulation of intracellular calcium levels, either through receptor-mediated signaling or by blocking calcium channels, can have a significant impact on PCDH19's calcium-dependent adhesion properties.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Directly stimulates adenylyl cyclase, which increases intracellular levels of cAMP. Elevated cAMP may enhance PCDH19-mediated cell-cell communication by influencing cytoskeletal organization and the formation of adherens junctions. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
A beta-adrenergic agonist that elevates intracellular cAMP through G-protein coupled receptor signaling. Increased cAMP can potentiate PCDH19's role in calcium-dependent cell adhesion processes. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
An activator of protein kinase C (PKC) which can phosphorylate and alter the function of proteins involved in cell adhesion, potentially enhancing PCDH19's stability and interaction with the cytoskeleton. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Activates adrenergic receptors leading to increased cAMP production, which could indirectly support PCDH19-mediated cell adhesion and signaling. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Modulates gene expression by activating retinoic acid receptors, influencing cell differentiation and potentially upregulating PCDH19 expression in neuronal and epithelial tissues. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits glycogen synthase kinase-3 beta, which may stabilize the cytoskeleton and enhance PCDH19's cell adhesion function. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
A selective inhibitor of phosphodiesterase 4 (PDE4), increasing cAMP levels and potentially facilitating PCDH19's role in cell-cell junction formation. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Binds to its G-protein coupled receptors and can increase intracellular calcium levels, which may positively influence PCDH19's calcium-dependent cell-cell adhesion. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A membrane-permeable cAMP analog that can mimic the action of cAMP, potentially enhancing PCDH19 function in cell-cell communication. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
A calcium channel blocker that modulates calcium influx, indirectly influencing PCDH19's calcium-dependent adhesion properties in neuronal cells. | ||||||